847 results on '"Jacqz-Aigrain, Evelyne"'
Search Results
2. Use of Machine Learning for Dosage Individualization of Vancomycin in Neonates
3. Optimization of Vancomycin Initial Dose in Term and Preterm Neonates by Machine Learning
4. Predictive Performance of Pharmacokinetic Model-Based Virtual Trials of Vancomycin in Neonates: Mathematics Matches Clinical Observation
5. Pharmacokinetics of mycophenolic acid and external evaluation of two limited sampling strategies of drug exposure in patients with juvenile systematic lupus erythematosus
6. Modalités pratiques de prise en charge en cours de traitement d’entretien des leucémies aiguës lymphoblastiques pédiatriques : recommandations du Comité leucémies de la Société française de lutte contre les cancers et les leucémies de l’enfant et de l’adolescent (SFCE)
7. Agreement between a regional pharmacovigilance centre and an adjudication committee regarding adverse drug reactions on a cohort of hospitalised children
8. Drug Clearance in Neonates: A Combination of Population Pharmacokinetic Modelling and Machine Learning Approaches to Improve Individual Prediction
9. Relationship between adverse drug reactions and unlicensed/off-label drug use in hospitalized children (EREMI): A study protocol
10. Paediatric clinical research in Europe: an insight on experts’ needs and perspectives
11. A physiological approach to renal clearance: From premature neonates to adults.
12. Population pharmacokinetics and dose optimization of ceftriaxone for children with community-acquired pneumonia
13. Key factors associated with 6‐thioguanine and 6‐methylmercaptopurine nucleotide concentrations in children treated by thiopurine for acute leukaemia and inflammatory bowel disease
14. UPLC/MS/MS assay for the simultaneous determination of seven antibiotics in human serum–Application to pediatric studies
15. Key factors associated with 6‐thioguanine and 6‐methylmercaptopurine nucleotide concentrations in children treated by thiopurine for acute leukaemia and inflammatory bowel disease.
16. Tacrolimus Bayesian dose adjustment in pediatric renal transplant recipients
17. Pharmacogenetics and application in pediatrics
18. Drug evaluation in children 10 years after the European pediatric regulation current challenges and perspectives
19. Principles and applications of pharmacometrics in drug evaluation in children
20. Favorable pharmacokinetics and pharmacodynamics properties of Gilteritinib in cerebrospinal fluid: a potential effective treatment in relapsing meningeal acute myeloid leukaemia FLT3-ITD patients
21. Pharmacogenetics of post-transplant diabetes mellitus in children with renal transplantation treated with tacrolimus
22. Sequential analysis in neonatal research—systematic review
23. Adverse Events under Tacrolimus and Cyclosporine in the First 3 Years Post-Renal Transplantation in Children
24. Evidence of voriconazole pharmacokinetic variability in children and adolescents with haematological disease: proposal for therapeutic drug monitoring optimisation
25. Evaluation of a pediatric liquid formulation to improve 6-mercaptopurine therapy in children
26. Safety study of Ciprofloxacin in newborn mice
27. Pharmacogenetics: Applications to Pediatric Patients
28. Improved HPLC Quantification of 6-Mercaptopurine Metabolites in Red Blood Cells: Monitoring Data and Literature Analysis
29. Principles of Therapeutic Drug Monitoring
30. Predicting CYP3A‐mediated midazolam metabolism in critically ill neonates, infants, children and adults with inflammation and organ failure
31. Growth Outcomes After GH Therapy of Patients Given Long-Term Corticosteroids for Juvenile Idiopathic Arthritis
32. Recruitment in pediatric clinical research was influenced by study characteristics and pediatricians' perceptions: a multicenter survey
33. Analysis of Paediatric Clinical Trial Characteristics and Activity Over 23 Years—Impact of the European Paediatric Regulation on a Single French Clinical Research Center
34. Pharmacokinetic Studies in Neonates: The Utility of an Opportunistic Sampling Design
35. A loss-of-function IFNAR1 allele in Polynesia underlies severe viral diseases in homozygotes
36. How paediatric drug development and use could benefit from OMICs: A c4c expert group white paper
37. EDITORIAL COMMENTARY: Effectiveness or Efficacy: Which Study to Evaluate Antibiotics in Neonates?
38. Licensed medicines, off-label use or evidence-based. Which is most important?
39. Prevalence of herpesviruses at onset of idiopathic nephrotic syndrome
40. Optimised versus standard dosing of vancomycin in infants with Gram-positive sepsis (NeoVanc): a multicentre, randomised, open-label, phase 2b, non-inferiority trial
41. First Dose in Neonates: Are Juvenile Mice, Adults and In Vitro–In Silico Data Predictive of Neonatal Pharmacokinetics of Fluconazole
42. Dosage individualization in children: integration of pharmacometrics in clinical practice
43. Outcome associated with prescription of cardiac rehabilitation according to predicted risk after acute myocardial infarction: Insights from the FAST-MI registries
44. Author’s Reply to Standing et al. Pharmacokinetic Studies in Neonates: The Utility of an Opportunistic Sampling Design
45. Tacrolimus Bayesian Dose Adjustment in Pediatric Renal Transplant Recipients
46. Evaluation of a pediatric liquid formulation to improve 6-mercaptopurine therapy in children
47. Amikacin Maturation Model as a Marker of Renal Maturation to Predict Glomerular Filtration Rate and Vancomycin Clearance in Neonates
48. Pharmacologie des anti-infectieux en période néonatale
49. Population pharmacokinetics and dosing optimization of teicoplanin in children with malignant haematological disease
50. Suivi thérapeutique pharmacologique des 6-thioguanine nucléotides dans les leucémies aigues lymphoblastiques de l’enfant : intérêt et limites
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.